213 related articles for article (PubMed ID: 11853322)
1. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
3. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy.
Zürcher AW; Molenaers G; Desloovere K; Fabry G
Acta Orthop Belg; 2001 Dec; 67(5):475-80. PubMed ID: 11822078
[TBL] [Abstract][Full Text] [Related]
4. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
5. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G
Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987
[TBL] [Abstract][Full Text] [Related]
6. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.
Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S
Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.
Corry IS; Cosgrove AP; Duffy CM; McNeill S; Taylor TC; Graham HK
J Pediatr Orthop; 1998; 18(3):304-11. PubMed ID: 9600553
[TBL] [Abstract][Full Text] [Related]
9. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.
Ackman JD; Russman BS; Thomas SS; Buckon CE; Sussman MD; Masso P; Sanders J; D'Astous J; Aiona MD;
Dev Med Child Neurol; 2005 Sep; 47(9):620-7. PubMed ID: 16138670
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
11. Influence of equinus treatments on the vertical displacement of the body's centre of mass in children with cerebral palsy.
Massaad F; van den Hecke A; Renders A; Detrembleur C
Dev Med Child Neurol; 2006 Oct; 48(10):813-8. PubMed ID: 16978460
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of gastrocnemius-soleus complex lengthening for isolated equinus contracture in children with cerebral palsy.
Tylkowski CM; Horan M; Oeffinger DJ
J Pediatr Orthop; 2009; 29(7):771-8. PubMed ID: 20104161
[TBL] [Abstract][Full Text] [Related]
13. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of botulinum toxin A in children with cerebral palsy.
Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
[TBL] [Abstract][Full Text] [Related]
15. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy.
Hayek S; Gershon A; Wientroub S; Yizhar Z
J Bone Joint Surg Br; 2010 Aug; 92(8):1152-9. PubMed ID: 20675764
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
18. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
19. Kinematic and dynamic analysis of the ankle joint in children with cerebral palsy.
Galli M; Fazzi E; Motta F; Crivellini M
Funct Neurol; 1999; 14(3):135-40. PubMed ID: 10568213
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
